Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Transfer of Final Bulk for Bottling – V 2.0

Posted on By

Elixir Department: SOP for Transfer of Final Bulk for Bottling – V 2.0

Standard Operating Procedure for Transfer of Final Bulk Elixir for Bottling

Department Elixir Department
SOP No. SOP/ELX/099/2025
Supersedes SOP/ELX/099/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define a standardized procedure for the safe, hygienic, and documented transfer of final bulk elixir from the manufacturing area to the bottling/filling section to maintain product integrity and traceability.

2. Scope

This SOP applies to all final elixir products in bulk form approved for bottling in the Elixir Department, including those held in manufacturing or intermediate holding tanks.

3. Responsibilities

  • Production Operator:
    • Perform transfer as per SOP and ensure all connections are clean and sanitized.
  • Production Supervisor:
    • Verify line clearance and approve transfer initiation.
  • QA Officer:
    • Approve product for bottling and verify line clearance and labeling.
See also  Elixir Department: SOP for Refractive Index Determination - V 2.0

4. Accountability

The Head of Production is accountable for ensuring safe, GMP-compliant transfer of final elixir product to the bottling area, maintaining documentation and batch traceability.

5. Procedure

5.1 Prerequisites

  1. Ensure the batch is
approved by QC and QA for further processing.
  • Verify volume as per BMR and confirm product identity labeling on the transfer container.
  • Complete line clearance of the bottling area and record it in the Line Clearance Record (Annexure-1).
  • 5.2 Transfer Line Setup

    1. Ensure all hoses, pipes, pumps, and transfer tanks are cleaned, sanitized, and dried.
    2. Use dedicated and labeled transfer lines or thoroughly cleaned multipurpose lines.
    3. Ensure transfer path is as short as possible to minimize exposure risk.

    5.3 Transfer Process

    1. Initiate transfer using gravity or low-pressure pump depending on layout.
    2. Maintain a closed-loop transfer system to prevent contamination or evaporation loss.
    3. Monitor flow rate and avoid foaming or splashing during transfer.
    4. Label the receiving tank or holding vessel with product name, batch number, and status (“Ready for Bottling”).

    5.4 Post-Transfer Activities

    1. Flush the transfer line with a small quantity of the same product and add it back to the main batch if applicable.
    2. Clean and dry all equipment and lines used for transfer immediately after completion.
    3. Record all details in the Transfer Log (Annexure-2).

    5.5 Documentation

    1. Document the following in BMR and Annexure-2:
      • Transfer date and time
      • Volume transferred
      • Operator and supervisor signatures
      • Transfer line ID
    2. QA shall verify product label and sign the log before bottling begins.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • BMR: Batch Manufacturing Record
    • QA: Quality Assurance
    • QC: Quality Control

    7. Documents

    1. Line Clearance Record (Annexure-1)
    2. Bulk Transfer Log (Annexure-2)
    3. Batch Manufacturing Record (BMR)

    8. References

    • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
    • WHO GMP Guidelines for Pharmaceutical Products

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Line Clearance Record

    Date Area Cleared By Checked By (QA) Remarks
    11/04/2025 Bottling Area – Line 2 Rajesh Kumar Sunita Reddy No previous material residues

    Annexure-2: Bulk Transfer Log

    Date Batch No. Volume Transferred (L) Transfer Line ID Operator Supervisor QA Verified
    11/04/2025 ELX-1038 995 L TL-05 Rajesh Kumar Meena Sharma Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Added Annexures and clarified transfer validation steps Process Compliance Update QA Head
    See also  Elixir Department: SOP for Use of Vacuum Transfer Systems - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Biosimilars: SOP for Carbon Dioxide Sparging – V 2.0
    Next Post: Creams: SOP for Verifying Batch Reconciliation during Production – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version